| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |